Recent healthcare and political changes are opening the door for medical device companies.
As competition for market share and investors tightens, well-designed market research can significantly enhance a medtech company’s strategy.
The felony charges involve stealing confidential product information for use with a competitor.
In addition to tax incentives in China, U.S. manufacturers are seeking Chinese partners due to a lack of domestic funding.
Despite the growth, total knee replacements are declining in average selling price.
Foreign companies can capitalize on offering their products in Asia but must be prepared to do so at a lower price.
The union will strengthen BD’s leadership in medication management and infection prevention, and increase opportunities in fast-growing clinical areas and OUS markets.
Medtronic will keep its respiratory and monitoring solutions business, while Cardinal will buy the patient care, DVT, and nutritional insufficiency businesses.
Tariffs on imports will hurt business expansion in Asia.
The $435-million deal is part of the company’s commitment to being a leader in products for transcatheter aortic valve implantation.